Life Sciences investors in Paris

452 investors — 417 funds and corporates plus 35 individual angels — have funded 137 Life Sciences companies head-officed in Paris, across 935 rounds (May 1999 – May 2026). They are ranked by how many Paris companies in this market they have actually backed.

"In Paris" describes the companies, not the investor: most of the money in any city comes from somewhere else, and the Where the money comes from section below shows exactly where it came from here.

The investors

Funds, corporates and individual angels together — everyone recorded funding a Life Sciences company in Paris. Ranked by companies backed here, then by round count. "Led" counts rounds recorded with this investor as lead.

#	Investor	Type	Based in	Stages here	Companies	Rounds	Led	Latest	Portfolio total
1	Bpifrance	Fund	Maisons Alfort, France	Series BSeries ASeries C	40	53	19	May 2026	936
2	Sofinnova Partners	Fund	Paris, France	Series BSeries ASeries C	21	43	27	Mar 2026	149
3	Kurma Partners	Fund	Paris, France	Series ASeedSeries B	13	23	8	Apr 2025	61
4	Idinvest Partners	Fund	Paris, France	SeedSeries ASeries B	11	18	6	Jul 2021	246
5	Omnes Capital	Fund	Paris, France	Series ASeries BPE	10	18	2	Jan 2025	149
6	Seventure Partners	Fund	Paris, France	Series ASeries CSeries B	8	18	7	Nov 2023	175
7	Invus	Fund	New York City, United States	Series BPost-IPOSeries A	6	9	2	Mar 2026	174
8	Edmond de Rothschild	Fund	Paris, France	Series CSeries ASeries B	6	9	5	Apr 2016	60
9	Karista	Fund	Paris, France	Series BSeries CSeed	5	10	1	Sep 2024	75
10	Elaia	Fund	Paris, France	SeedSeries ASeries B	5	7	3	Jan 2026	131
11	Entrepreneur First	Fund	London, United Kingdom	Series ASeed	5	6	2	May 2025	292
12	BNP Paribas Developpement	Fund	Paris, France	Series ASeries B	5	6	2	Jul 2022	116
13	Kima Ventures	Fund	Paris, France	SeedSeries A	5	5	1	Jul 2025	636
14	Cathay Innovation	Fund	San Francisco, United States	Series ASeed	4	9	4	Jan 2025	94
15	M Ventures	Fund	Amsterdam, Netherlands	Series ASeries BSeries C	4	7	2	Jun 2023	95
16	XAnge	Fund	Paris, France	Series DSeries BSeed	4	7	2	Feb 2026	101
17	Abingworth	Fund	London, United Kingdom	Series ASeries B	4	7	2	Nov 2013	98
18	Eurazeo	Fund	Paris, France	Series ASeries CSeries B	4	5	1	Dec 2024	191
19	Casdin Capital	Fund	New York City, United States	Series BSeries ASeries C	4	5	2	Dec 2021	136
20	GO CAPITAL	Fund	Rennes, France	Series BSeries A	4	5	1	Feb 2026	101
21	Healthcap	Fund	Stockholm, Sweden	Series BSeries A	4	5	2	Mar 2017	68
22	Plug and Play Tech Center	Fund	Sunnyvale, United States	Series ASeed	4	4	1	Jun 2025	934
23	BNP Paribas	Fund	Paris, France	Series BSeries ASeries C	4	4	1	Feb 2026	153
24	EIC Fund	Fund		Series BSeries A	4	4	4	Nov 2023	134
25	Turenne Capital	Fund		Series BSeries A	4	4	1	Jan 2025	90
26	Andera Partners	Fund	Paris, France	Series BSeries A	4	4	2	Feb 2025	56
27	AdBio partners	Fund	Paris, France	Seed	4	4	1	Jun 2023	12
28	Truffle Capital	Fund	Paris, France	Series BPost-IPO	3	6	5	Jan 2024	53
29	Ysios Capital	Fund	Barcelona, Spain	Series BSeries ASeries C	3	5	1	Sep 2022	40
30	Paris Business Angels	Fund	Paris, France	Series ASeed	3	5	1	Dec 2024	53
31	Novo Holdings	Fund	Hellerup, Denmark	Series BSeries A	3	4	3	Jan 2025	286
32	Alexandria	Fund	Pasadena, United States	Series BSeries ASeries C	3	4	—	Dec 2021	231
33	Verve Ventures	Fund	Berlin, Germany	Series BSeries ASeed	3	4	—	May 2025	142
34	Cathay Capital	Fund	Paris, France	Series CPESeries B	3	4	3	May 2023	127
35	Fountain Healthcare Partners	Fund	Dublin, Ireland	Series BSeries A	3	4	1	Sep 2023	28
36	Debiopharm	Fund	Lausanne, Switzerland	Post-IPOSeries A	3	4	4	Mar 2023	33
37	Jeito	Fund	Paris, France	Series BSeries A	3	4	2	Sep 2023	22
38	M&L Healthcare	Fund	Singapore, Singapore	Series CSeries BSeries A	3	4	1	Sep 2025	7
39	Orbimed	Fund	New York City, United States	PEPost-IPOSeries A	3	3	2	Sep 2023	422
40	Novartis Venture Fund	Fund	Basel, Switzerland	Series ASeries B	3	3	2	Mar 2017	139
41	Credit Mutuel Equity	Fund	Paris, France	Series ASeries B	3	3	1	Jul 2022	126
42	Johnson & Johnson Innovation	Fund	New Brunswick, United States	Post-IPOSeed	3	3	1	Dec 2023	102
43	MACSF	Fund	La Defense, France	Series ASeries CSeed	3	3	1	Jan 2026	14
44	eureKARE	Fund	Luxembourg, Luxembourg	Series BSeries CSeed	3	3	2	Nov 2022	4
45	Sofinnova Partners	Fund	Paris, France	Series BSeries ASeries C	2	6	5	Jul 2011	45
46	Google Ventures	Fund	Mountain View, United States	Series A	2	5	1	Dec 2025	736
47	LBO France	Fund	Paris, France	Series DSeries ASeries B	2	5	1	Jun 2025	38
48	Life Sciences Partners	Fund	Amsterdam, Netherlands	Series BSeries ASeries C	2	4	2	Oct 2021	105
49	Caphorn	Fund	Paris, France	Series ASeries BSeries C	2	4	4	Jan 2023	54
50	NJF Capital	Fund	London, United Kingdom	Series ASeed	2	4	—	Feb 2024	14
51	LocalGlobe	Fund	London, United Kingdom	SeedSeries A	2	3	1	Feb 2025	208
52	Pontifax	Fund	Herzliya, Israel	Series ASeries B	2	3	—	Jul 2021	74
53	Credit Agricole	Fund	Montrouge, France	PESeries ASeries B	2	3	2	Dec 2007	99
54	Frst Capital	Fund	Paris, France	Series ASeed	2	3	1	Feb 2024	37
55	V-Bio Ventures	Fund	Ghent, Belgium	Series BSeedSeries A	2	3	—	Sep 2023	25
56	Innovation Capital	Fund	Paris, France	Series ASeries C	2	3	3	Nov 2015	27
57	Arix Bioscience	Fund	London, United Kingdom	Post-IPOSeries A	2	3	1	Dec 2021	23
58	Pureos Bioventures	Fund	Pfaffikon, Switzerland	SeedSeries B	2	3	1	Feb 2024	19
59	Fund+	Fund	Leuven, Belgium	Series BSeries A	2	3	—	Jan 2025	16
60	Sham	Fund	Lyon, France	Series BSeries A	2	3	—	Jul 2021	17
61	Aurinvest	Fund	Paris, France	Series BSeed	2	3	—	Nov 2021	15
62	Matignon	Fund	Paris, France	Series BSeries CSeries A	2	3	—	Sep 2010	11
63	Inserm Transfert Initiative	Fund	Paris, France	Series ASeed	2	3	—	Sep 2016	8
64	Mutuelles Impact	Fund	Paris, France	Series BSeries ASeries C	2	3	—	Feb 2026	9
65	Paris Saclay Seed Fund	Fund	Saint Aubin, France	Series BSeedSeries A	2	3	1	Feb 2022	4
66	Fidelity Investments	Fund	Boston, United States	Series BSeries C	2	2	1	Oct 2021	358
67	Versant Ventures	Fund	Basel, Switzerland	Series A	2	2	1	Apr 2014	174
68	European Union	Fund	Belgium	SeedSeries C	2	2	1	May 2025	195
69	Redmile Group	Fund	San Francisco, United States	Series A	2	2	1	Jul 2025	113
70	Newfund	Fund	Paris, France	SeedSeries A	2	2	2	Sep 2020	133
71	UI Investissement	Fund	Paris, France	Series BSeries A	2	2	—	Jan 2025	150
72	Pfizer	Fund	New York City, United States	Series BSeed	2	2	2	Jan 2026	110
73	Societe Generale	Fund	Paris, France	Series ASeries B	2	2	—	Jun 2020	88
74	Xavier Niel	Angel	Paris, France	SeedAngel	2	2	1	Feb 2024	78
75	Bristol-Myers Squibb	Fund	New York City, United States	Series DSeries B	2	2	1	Jun 2022	64
76	Otium Capital	Fund	Paris, France	Series ASeed	2	2	1	Dec 2023	51
77	Takeda	Fund	Tokyo, Japan	Series E+Series A	2	2	1	Oct 2021	48
78	Amundi	Fund	Paris, France	Series BSeries C	2	2	—	Apr 2013	45
79	Merieux Equity Partners	Fund	Lyon, France	PESeries D	2	2	1	May 2023	36
80	Odyssee Venture	Fund	Paris, France	Series APost-IPO	2	2	1	Feb 2026	41
81	Asabys Partners	Fund	Barcelona, Spain	Series ASeries C	2	2	2	Sep 2025	21
82	APICAP	Fund	Paris, France	Series CPost-IPO	2	2	1	Apr 2011	24
83	Blast.Club	Fund	Paris, France	Series A	2	2	1	Apr 2025	23
84	Angels Sante	Fund	Paris, France	SeedSeries A	2	2	2	Oct 2019	19
85	Polytechnique Ventures	Fund	Paris, France	SeedSeries A	2	2	1	Jul 2025	15
86	Teampact Ventures	Fund	Paris, France	Series DSeed	2	2	1	Apr 2026	14
87	Financiere Arbevel	Fund	Paris, France	Series ASeries C	2	2	—	Jan 2021	13
88	Top Harvest Capital	Fund	Menlo Park, United States	Series ASeed	2	2	—	Feb 2024	12
89	UPMC Enterprises	Fund	Pittsburgh, United States	Series BPost-IPO	2	2	1	Mar 2026	12
90	Malakoff Humanis	Fund	Paris, France	Series CSeries B	2	2	—	Oct 2025	10
91	Inserm Transfert	Fund	Paris, France	Series BSeries A	2	2	—	Jan 2020	7
92	Octave Klaba	Angel	Roubaix, France	Seed	2	2	—	Nov 2022	6
93	Groupe Prunay	Fund	Louveciennes, France	Series A	2	2	—	Dec 2024	3
94	MD Start	Fund	Paris, France	Seed	2	2	1	Jun 2011	3
95	Valquest Capital Management	Fund	New York City, United States	Series ASeries B	2	2	2	Nov 2019	2
96	Lundbeck Foundation	Fund	Copenhagen, Denmark	Series DSeries ASeries B	1	4	3	Jan 2018	39
97	Illumina Ventures	Fund	Foster City, United States	Series ASeries BSeries C	1	4	—	Oct 2021	40
98	Eight Roads Ventures	Fund	London, United Kingdom	Series A	1	3	1	Jun 2020	333
99	F-Prime Capital	Fund	Cambridge, United States	Series A	1	3	1	Jun 2020	306
100	Boehringer Ingelheim Venture Fund	Fund	Ingelheim am Rhein, Germany	Series BSeedSeries A	1	3	1	Jan 2020	54

Showing the top 100 of 452. Search the full investor set →

The companies they funded

Life Sciences companies head-officed in Paris that took money from these investors.

Company	Backers	Rounds	Disclosed	Latest round
DNA Script Developer of benchtop DNA printer for nucleic acid synthesis	24	43	$3.6B	Series C Jan 2022
HiFiBiO Provider of a technology platform for the discovery of antibody-based drugs	20	27	$1.6B	Series D Jun 2021
Owkin AI generative biology company to create the new standard of biology reasoning	19	35	$724.4M	Series B Mar 2026
Wandercraft Provider of AI-powered exoskeleton solutions	17	26	$1.3B	Series D Jun 2025
Bioptimus Developer of AI foundation model to transform biological research	17	20	$760M	Series A Jan 2025
Coave Therapeutics Developer of gene therapy for ocular and neurological disease	17	23	$739.6M	Series B Jan 2025
Biomemory Online platform offering bio-digital data storage solutions	17	18	$208.8M	Series A Dec 2024
GenSight Biologics Developer of viral vector-based gene therapies for retinal neurodegenerative diseases	16	21	$379.4M	Post-IPO Mar 2026
Abivax Developer of therapeutics for chronic inflammatory diseases	13	18	$1.7B	Post-IPO Feb 2023
TISSIUM Developer of vascular sealant for open vascular surgery	13	16	$774.6M	Series D May 2023
DeepLife Provider of AI-based drug discovery and omics analysis tool for researchers	13	13	$94.9M	Series A Dec 2024
PulseSight Developer of non-viral minimally invasive gene therapies for retinal diseases	11	20	$306.7M	Seed Feb 2024
Spore Biotechnologies Developer of microbial detection technology for life science industries	11	13	$212.7M	Series A Feb 2025
Inotrem Developer of peptide immunotherapies for treating septic shock and acute myocardial infarction	10	13	$467.4M	Series B Feb 2020
CorWave Developer of implantable blood pumps for the treatment of heart failure	10	14	$452.9M	Series C Jun 2023
Enodia Therapeutics Developer of small-molecule therapies for inflammatory and autoimmune diseases	10	10	$250M	Seed Jan 2026
SpineVision Developer of implants for spinal treatment	10	15	$145.1M	Series B May 2013
Primaa Provider of AI-based software for detection of cancer	10	10	$55.4M	Series B Oct 2025
Brink Therapeutics Developer of cell and gene therapies to treat various diseases	10	10	$40M	Seed Apr 2025
Enterome Developer of immunomodulatory drugs targeting cancer and immune diseases	9	22	$652.8M	Series E+ Jun 2020
Inato AI-based patient recruitment platform	9	13	$143.6M	Series A Mar 2023
Novexel Developer of antibacterial and antifungal agents to treat bacterial and fungal infections	8	13	$789.1M	Series B Jan 2007
SparingVision Developer of drugs using gene therapy to treat retinitis pigmentosa	8	12	$768.4M	Series B Sep 2022
Fovea Pharmaceuticals Drugs for retinal pathologies & other ocular diseases	8	13	$414M	Series B Dec 2007
SafeHeal Developer of a medical device for colorectal surgery	8	15	$326.5M	Series C Sep 2025
Carthera Devices focused on the treatment of brain tumors	8	11	$210M	Series B Dec 2023
EOS Iamging Developer of 2d/3D orthopedic imaging and software solutions	8	13	$209.5M	Post-IPO Jul 2018
Diaxonhit Fully integrated in vitro diagnostics company specializing in transplantation, infectious diseases and cancer diagnosis	8	12	$200.5M	Series C Dec 2001
One Biosciences Developer of single-cell therapeutics solutions to treat multiple health disorders	8	8	$139.4M	Series A Jul 2025
Chipiron Developer of portable MRI machines	8	8	$91.5M	Series A Apr 2025
Nanobiotix Developer of nanotherapeutics designed to enhance cancer treatment via radioenhancement	8	8	$81.8M	Post-IPO Dec 2023
PathoQuest Provider of next-generation sequencing for microbiology testing	8	14	$35M	Series B Nov 2021
Corteria Pharmaceuticals Developer of therapeutics for the treatment of heart failure	7	11	$542.3M	Series A Sep 2023
Vivet Therapeutics Developer of gene therapies for inherited metabolic diseases	7	7	$288.1M	Series B Mar 2019
HighLife Medical Developer of trans-catheter mitral valve replacement system	7	8	$211M	Series B Dec 2020
Genticel Developer of immunotherapies to treat infectious diseases and cervical cancer using CyaA vector technology	7	10	$207M	Series C Apr 2013
Robeauté Developer of microrobots for neurosurgical applications	7	7	$196M	Seed Jan 2025
TheraVectys Developer of vaccines to treat infectious diseases and cancer caused by HTLV-1 infection	7	8	$91.3M	Series C Oct 2013
Syremis Developer of novel medicines for mental health conditions	6	6	$990M	Series A Dec 2025
BioSerenity Provider of smart healthcare solutions for sleep and EEG lab management	6	10	$382.3M	PE Nov 2023
Cellectis Developer of cancer immunotherapies based on gene-edited CAR T-cells	6	7	$357.2M	Post-IPO May 2024
Pixium Vision Provider of bionic vision restoration systems	6	8	$153.1M	Post-IPO Jan 2021
Dreem Provider of wearable sleep tracking device	6	6	$122M	Series B Jun 2018
Ganymed Robotics Surgical robotic assistants for orthopedic surgeons	6	6	$115.4M	Series B Jan 2023
AFYREN Provider of analytical services for microbiology, chemistry and bioprocesses industries	6	6	$109.9M	Post-IPO Feb 2026
Brightflow Developer of medical device to treat right-sided heart failure	6	6	$109.7M	Series A Sep 2024
Lifeaz Developer of connected defibrillators	6	7	$97.4M	Series B Feb 2026
Acticor Biotech Developing immunotherapeutics for treating ischemic stroke	6	11	$92M	Series B Nov 2019
Sensome Developer of a smart guidewire with sensors is designed to provide precise information on the clot composition	6	12	$82.8M	Series B Jan 2020
Neovacs CDMO focused on manufacturing of vaccines	6	9	$67.6M	Post-IPO Dec 2018